Dapagliflozin Propanediol Hydrate is a sodium-glucose cotransporter-2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus, heart failure, and chronic kidney disease. This therapeutic… Read more
Dapagliflozin Propanediol Hydrate is a sodium-glucose cotransporter-2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus, heart failure, and chronic kidney disease. This therapeutic agent functions by inhibiting glucose reabsorption in the proximal tubule of the nephron, which facilitates urinary glucose excretion to support glycemic control. To satisfy the rigorous analytical requirements of pharmaceutical laboratories, this category features comprehensive reference standards for the active pharmaceutical ingredient. Laboratories rely on these materials, including identified impurities and metabolites, for precise impurity profiling, method validation, and stability testing. Furthermore, stable isotope labelled compounds are available to serve as critical internal standards in quantitative analysis, assisting researchers in maintaining high levels of accuracy and regulatory compliance during drug development, bioanalytical studies, and routine quality control procedures.